The "STAR" studies: Which antihypertensive strategy to choose in patients with uncontrolled mild-to-moderate hypertension?

被引：0
作者：
Boissel, JP
Laurent, S
Wimart, MC
Hoden, S
Baleydier, A
机构：
[1] Laennec Med Sch, Dept Pharmacol, Lyon, France
[2] Hop Broussais, F-75674 Paris, France
[3] AstraZeneca, Rueil Malmaison, France
[4] RCTs, Vaulx En Velin, France
来源：
JOURNAL OF HYPERTENSION | 2000年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S102 / S102
页数：1
相关论文
共 50 条
  • [21] The antihypertensive efficacy and safety of irbesartan compared with amlodipine for the treatment of mild-to-moderate hypertension.
    Neutel, J
    Germino, W
    Smith, D
    Park, JS
    Reilly, K
    Triscari, J
    AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) : 128A - 128A
  • [22] NITRENDIPINE TREATMENT OF MILD-TO-MODERATE HYPERTENSION
    VITACOLONNA, E
    GUAGNANO, MT
    CAPANI, F
    SENSI, S
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1986, 39 (03): : 414 - 420
  • [23] METOPROLOL OR ATENOLOL FOR MILD-TO-MODERATE HYPERTENSION
    LYNGSTAM, O
    RYDEN, L
    LANCET, 1979, 2 (8143) : 634 - 634
  • [24] Comparison of antihypertensive efficacy of carvedilol and nebivolol in mild-to-moderate primary hypertension: a randomized trial
    Erdogan, Okan
    Ertem, Bulent
    Altun, Armagan
    ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY, 2011, 11 (04): : 310 - 313
  • [25] Antihypertensive efficacy of two angiotensin II receptor antagonists, valsartan and telmisartan, in patients with mild-to-moderate essential hypertension
    Calvo, C
    Hermida, RC
    Ayala, DE
    Lopez, JE
    Dominguez, MJ
    Fernandez, JR
    Mojon, A
    Covelo, M
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (05) : 109A - 110A
  • [26] Lipid peroxidation is not increased in patients with untreated mild-to-moderate hypertension
    Cracowski, JL
    Baguet, JP
    Ormezzano, O
    Bessard, J
    Stanke-Labesque, F
    Bessard, G
    Mallion, JM
    HYPERTENSION, 2003, 41 (02) : 286 - 288
  • [27] A COMPARISON OF FELODIPINE AND NIFEDIPINE AS MONOTHERAPY IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION
    GOUDIE, AW
    GUPTA, OP
    GRAY, PL
    ROSS, JRM
    GOVES, JR
    MCKENNA, BJ
    BLOMFIELD, IA
    BRAMLEY, KW
    SHARP, RW
    JONES, DF
    HADLEY, RJ
    WATTS, DA
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1994, 55 (06): : 625 - 631
  • [28] EXTENDED-RELEASE FELODIPINE IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION
    WEBER, MA
    GOLDBERG, AI
    FAISON, EP
    LIPSCHUTZ, K
    SHAPIRO, DA
    NELSON, EB
    IRVIN, JD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (03) : 346 - 352
  • [29] Cost-effectiveness of indapamide in patients with mild-to-moderate hypertension
    Stafylas, PC
    Sarafidis, PA
    Lasaridis, AN
    Aletras, VH
    VALUE IN HEALTH, 2005, 8 (06) : A106 - A106
  • [30] ISRADIPINE IN THE TREATMENT OF MILD-TO-MODERATE HYPERTENSION IN GERIATRIC-PATIENTS
    ROCHAGONCALVES, F
    MOURA, B
    PEREIRAMIGUEL, JM
    CORREANUNES, A
    MARIANOPEGO, G
    AMERICAN JOURNAL OF HYPERTENSION, 1994, 7 (07) : S64 - S66
12345